7 related articles for article (PubMed ID: 38742822)
1. New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.
Wu PC; Huang IH; Wang CY; Chi CC
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793716
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the outcomes of dermatoses during the COVID-19 outbreak in China: a retrospective study.
Li JH; Li SZ; Wang SH; Zhang J; Xie YH; Zuo YG
Front Med (Lausanne); 2024; 11():1417358. PubMed ID: 38873214
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial burden of autoimmune blistering diseases: A comprehensive survey study.
White MA; Hoffman VM; Yale M; Strong R; Tomayko MM
J Eur Acad Dermatol Venereol; 2024 Jun; ():. PubMed ID: 38837452
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study.
Amonchaisakda N; Rujitharanawong C; Tuchinda P; Kulthanan K; Chularojanamontri L
Exp Dermatol; 2024 May; 33(5):e15095. PubMed ID: 38742822
[TBL] [Abstract][Full Text] [Related]
5.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
6.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
